Colchicine resistance prediction criteria from the TURPAID cohort do not apply to the JIR cohort: a multicentre descriptive analysis

Lymphopenia drives T cell exhaustion in immunodeficient STING gain-of-function mice

Serum interleukin-18 levels are specifically elevated in auto-inflammatory diseases involving the pyrin inflammasome: A study on 516 patients

European Reference Network (ERN) ReCONNET methodology for the cross-cultural adaptation of instruments for research and care in the context of rare connective tissue diseases (CROSSADAPT)

New Diseases Linked to MEFV Variants or Pyrinopathies

Performance of serum IL-18 levels for the follow-up of patients with familial Mediterranean fever

Relapsing polychondritis: clinical updates and new differential diagnoses

Clinical images: Calabar swelling caused by Loa loa mimicking polyarthritis

Type 1 interferons: A target for immune-mediated inflammatory diseases (IMIDs)

Novel therapeutic strategies for autoimmune and inflammatory rheumatic diseases

Rheumatoid vasculitis in 2023: Changes and challenges since the biologics era

[Restatement. Relapsing polychondritis]

Relapsing polychondritis: Best Practice & Clinical Rheumatology

Bilateral gastrocnemius myositis: an extra-intestinal manifestation of Crohn's disease

Granulomatous manifestations associated with COVID19 infection: Is there a link between these two diseases?

Characterization of drug-induced cutaneous lupus: Analysis of 1994 cases using the WHO pharmacovigilance database

Clinical spectrum and therapeutic management of auto-immune myelofibrosis: a nation-wide study of 30 cases

Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

Characterizing drug-induced capillary leak syndromes using the World Health Organization VigiBase

The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis

Persistent Acrocyanosis-A Rare Manifestation Revealing Anti-PL-12 Syndrome

Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production

Levels of physical activity in a large international cohort of patients with systemic lupus erythematosus

Assessment and personalised advice for fatigue in systemic lupus erythematosus using an innovative digital tool: the Lupus Expert system for the Assessment of Fatigue (LEAF) study

New and future therapies: Changes in the therapeutic armamentarium for SLE

New biologics and targeted therapies in systemic lupus: From new molecular targets to new indications. A systematic review

Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus

Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a need for a more accurate control group?

Fatigue in Systemic Lupus Erythematosus: An Update on Its Impact, Determinants and Therapeutic Management

Patterns of fatigue and association with disease activity and clinical manifestations in systemic lupus erythematosus

Towards a practical management of fatigue in systemic lupus erythematosus

Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database

Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective study

Characterization of auto-immune hepatitis associated with the use of anti-TNFα agents: An analysis of 389 cases in VigiBase

[What is an undifferentiated systemic autoinflammatory disease in adults?]

[Autoinflammatory diseases associated with IL-18]

Identifying quality of life domains and facets affected in relapsing polychondritis: a qualitative analysis for the development of a disease-specific health-related quality of life instrument

Development and validation of a relapsing polychondritis disease-specific quality of life instrument (ERN ReCONNET RP-QoL)

Periosteal reactions and myalgias as an initial manifestation of paediatric Takayasu arteritis with delayed vascular involvement

Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective study

Could tocilizumab be used in familial Mediterranean fever? A systematic review

Refining Incidence and Characteristics of Inflammatory Myopathies: A Quadruple-Source Capture-Recapture Survey Using the 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria

[The kidney in gout and gout of the kidney]

Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event

Primary immunodeficiencies and lymphoma: a systematic review of literature

Primary immunodeficiencies and lymphoma: a systematic review of literature

c-myc mRNA expression in minor salivary glands of patients with Sjögren's syndrome